Senegalese company produces first Africa-made treatment for sickle cell disease
Now, a Senegalese pharmaceutical company has produced the first Africa-made treatment, raising hope for the millions of sufferers.
Teranga Pharma CEO, Mouhamadou Sow, said his company is producing a generic version of hydroxyurea, the gold standard in sickle cell treatment.
Africa accounts for nearly 80 per cent of cases of the inherited red blood cell disorder but relies on expensive imported medication from Europe and the Americas.
This is a summary of the original articles listed below. Always read the source articles for the full context. GhanaSummary does not create or modify the news — we summarise and link to original publishers.
